An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders

Clinical trial NCT01855074 · COMPLETED

Trial details

NCT number: NCT01855074
Sponsor: Janssen-Cilag Ltd.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophrenia Schizophreniform Disorder Schizoaffective Disorder

Start date: 2007-11-01
Primary completion: 2009-02-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.